|
Market Closed -
NSE India S.E.
12:22:03 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 3,095.90 INR | +0.70% |
|
+8.61% | +79.79% |
| 10-08 | Nomura Adjusts Gland Pharma's Price Target to INR3,750 From INR3,330, Keeps at Buy | MT |
| 10-05 | Indian shares open higher as Fed-hike fears, oil prices ease; financials lead | RE |
| Market Cap | 511B 5.38B 4.82B 4.43B 4.01B 7.5B 7.65B 52.84B 21.21B 269B 20.19B 19.76B 847B | P/E 2027 * |
38.9x | P/E 2028 * | 32x |
|---|---|---|---|---|---|
| Enterprise Value | 474B 4.99B 4.47B 4.11B 3.73B 6.97B 7.1B 49.06B 19.69B 249B 18.74B 18.34B 787B | EV / Sales 2027 * |
6.3x | EV / Sales 2028 * | 5.4x |
| Free-Float |
54.26% | Yield 2027 * |
0.66% | Yield 2028 * | 0.72% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLAND | Delayed | |
Bombay S.E.
| GLAND | Delayed |
Last Transcript: Gland Pharma Limited
| 1 day | +0.70% | ||
| 1 week | +8.61% | ||
| Current month | +6.78% | ||
| 1 month | +3.55% | ||
| 3 months | +21.71% | ||
| 6 months | +78.02% | ||
| Current year | +79.79% |
| 1 week | 2,788.4 |  | 3,114.2 |
| 1 month | 2,769.8 | | 3,171 |
| Current year | 1,573.6 | | 3,171 |
| 1 year | 1,573.6 | | 3,171 |
| 3 years | 1,277.8 | | 3,171 |
| 5 years | 861 | | 4,062.95 |
| 10 years | 861 | | 4,350 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 29/09/2019 | |
| Chief Operating Officer | - | 05/04/2026 | |
Jitendra Gangwal
CTO | Chief Tech/Sci/R&D Officer | - | 17/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Srinivas Sadu
CHM | Chairman | 57 | 09/06/2024 |
| Director/Board Member | 71 | 06/02/2018 | |
Naina Lal Kidwai
BRD | Director/Board Member | 69 | 16/05/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/02/25 | Buy | 2,800 | 0.0017% | |||
| 28/06/24 | Sell | 1,950 | 0.0012% | |||
| 28/06/24 | Sell | 1,400 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.70% | +8.61% | +62.56% | +99.61% | 5.33B | |
| +3.19% | +8.48% | +74.25% | +153.03% | 1,224B | |
| -0.73% | +2.09% | +46.41% | +87.64% | 662B | |
| +1.41% | +3.40% | +30.98% | +112.26% | 514B | |
| +0.42% | +2.88% | +54.92% | +69.67% | 388B | |
| +2.18% | +1.55% | +72.70% | +45.42% | 361B | |
| +1.12% | +3.80% | +35.82% | +59.72% | 302B | |
| +6.96% | +7.55% | +11.15% | +37.89% | 271B | |
| +1.15% | +4.19% | +59.72% | +78.16% | 249B | |
| +3.06% | +8.58% | +44.03% | +122.76% | 205B | |
| Average | +2.01% | +3.12% | +49.25% | +86.62% | 418.22B | |
| Weighted average by Cap. | +1.94% | +3.05% | +53.37% | +100.42% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 75.26B 793M 710M 653M 592M 1.11B 1.13B 7.79B 3.13B 39.59B 2.97B 2.91B 125B | 86.16B 907M 813M 748M 677M 1.27B 1.29B 8.91B 3.58B 45.32B 3.41B 3.33B 143B |
| Net income | 13.22B 139M 125M 115M 104M 194M 198M 1.37B 549M 6.96B 523M 512M 21.94B | 15.96B 168M 151M 138M 125M 235M 239M 1.65B 663M 8.4B 631M 617M 26.48B |
| Net Debt | -36.59B -385M -345M -317M -288M -538M -548M -3.79B -1.52B -19.25B -1.45B -1.42B -60.71B | -45.82B -483M -432M -398M -360M -673M -686M -4.74B -1.9B -24.1B -1.81B -1.77B -76.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ₹3,095.90 | +0.70% | 300,302 |
| 29/10/26 | ₹3,074.50 | +0.84% | 386,093 |
| 28/10/26 | ₹3,049.00 | +3.00% | 282,542 |
| 27/10/26 | ₹2,960.30 | +4.09% | 397,406 |
| 26/10/26 | ₹2,843.90 | +0.60% | 480,647 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAND Stock
Select your edition
All financial news and data tailored to specific country editions
